(Total Views: 344)
Posted On: 12/16/2020 11:35:37 AM
Post# of 36566
I couldn’t find the post to link to this response, but it was a concern that it might be difficult to find test volunteers for the NGIO Ii-Key vaccine trials. That will not be a problem. Read the article https://www.nbcnews.com/news/world/covid-19-v...s-n1251351
The world population is 7.8 billion and the US+EU = .78 billion. So with 7 billion people being left out of the mRNA vaccines until perhaps the end of next year or even later, and factor in that the Ii-Key vaccine could possibly be shipped in a power form to the most remote destitute corners of the planet, I don’t think that volunteer test subjects will be a problem. Once NGIO gets the ok to proceed to trial, I think that these left out countries will be putting their early orders in to insure that they are first in line to get the superior vaccine.
The world population is 7.8 billion and the US+EU = .78 billion. So with 7 billion people being left out of the mRNA vaccines until perhaps the end of next year or even later, and factor in that the Ii-Key vaccine could possibly be shipped in a power form to the most remote destitute corners of the planet, I don’t think that volunteer test subjects will be a problem. Once NGIO gets the ok to proceed to trial, I think that these left out countries will be putting their early orders in to insure that they are first in line to get the superior vaccine.
(3)
(0)
